T1	Disorder 33 44	anaphylaxis
N1 	Reference T1 UMLS:C0002792	anaphylaxis
T4	Pharmacological_substance 102 111	Protamine
N1000 	Reference T4 MeSH:D011479	Protamine
T5	Pharmacological_substance 167 174	heparin
N1001 	Reference T5 MeSH:D006493	heparin
T9	Pharmacological_substance 245 254	protamine
N1002 	Reference T9 MeSH:D011479	protamine
T10	Disorder 348 366	type I anaphylaxis
N2 	Reference T10 UMLS:C0002792	type I anaphylaxis
T13	Disorder 601 609	diabetic
N3 	Reference T13 UMLS:C0011860	diabetic
N4 	Reference T13 UMLS:C0011849	diabetic
T23	Pharmacological_substance 824 833	protamine
N1003 	Reference T23 MeSH:D011479	protamine
T24	Pharmacological_substance 837 846	protamine
N1004 	Reference T24 MeSH:D011479	protamine
T27	Pharmacological_substance 858 865	insulin
N1005 	Reference T27 MeSH:D007328	insulin
T30	Pharmacological_substance 988 997	protamine
N1006 	Reference T30 MeSH:D011479	protamine
T7	Pharmacological_substance 9 18	Protamine
N1007 	Reference T7 MeSH:D011479	Protamine
T18	Pharmacological_substance 382 391	protamine
N1008 	Reference T18 MeSH:D011479	protamine
T26	Pharmacological_substance 440 449	protamine
N1009 	Reference T26 MeSH:D011479	protamine
T31	Pharmacological_substance 504 513	protamine
N1010 	Reference T31 MeSH:D011479	protamine
T32	Subject 746 784	27 nondiabetic healthy normal controls
T33	Subject 788 800	10 diabetics
T36	Subject 592 600;610 618	10 of 19 patients
T37	Disorder 224 241	adverse reactions
N5 	Reference T37 UMLS:C0559546	adverse reactions
